期刊
CELL DEATH AND DIFFERENTIATION
卷 17, 期 7, 页码 1179-1188出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2009.220
关键词
lipoxin; macrophage; oxidative stress; nrf2
资金
- Ministerio de Ciencia e Innovacion (MICINN
- Spain) [BFU2008-02161]
- Comunidad de Madrid [S-BIO-0283/2006]
- FIS-RECAVA [RD06/0014/0025]
- Instituto de Salud Carlos III
Lipoxin A(4) (LXA(4)) is an endogenous lipid mediator that requires transcellular metabolic traffic for its synthesis. The targets of LXA(4) on neutrophils are well described, contributing to attenuation of inflammation. However, effects of lipoxins on macrophage are less known, particularly the action of LXA(4) on the regulation of apoptosis of these cells. Our data show that pretreatment of human or murine macrophages with LXA(4) at the concentrations prevailing in the course of resolution of inflammation (nanomolar range) significantly inhibits the apoptosis induced by staurosporine, etoposide and S-nitrosoglutathione or by more pathophysiological stimuli, such as LPS/IFN gamma challenge. The release of mitochondrial mediators of apoptosis and the activation of caspases was abrogated in the presence of LXA(4). In addition to this, the synthesis of reactive oxygen species induced by staurosporine was attenuated and antiapoptotic proteins of the Bcl-2 family accumulated in the presence of lipoxin. Analysis of the targets of LXA(4) identified an early activation of the PI3K/Akt and ERK/Nrf-2 pathways, which was required for the observation of the antiapoptotic effects of LXA(4). These data suggest that the LXA(4), released after the recruitment of neutrophils to sites of inflammation, exerts a protective effect on macrophage viability that might contribute to a better resolution of inflammation. Cell Death and Differentiation (2010) 17, 1179-1188; doi:10.1038/cdd.2009.220; published online 22 January 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据